Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BSX [NYSE]
Boston Scientific Corporation
Healthcare | Medical Devices | USA
statements
IndexS&P 500 P/E- EPS (ttm)-0.08 Insider Own0.30% Shs Outstand1.43B Perf Week1.96%
Market Cap57.32B Forward P/E21.65 EPS next Y1.83 Insider Trans-11.03% Shs Float1.40B Perf Month5.58%
Income-115.00M PEG- EPS next Q0.30 Inst Own92.70% Short Float1.30% Perf Quarter15.78%
Sales9.91B P/S5.78 EPS this Y-119.10% Inst Trans-2.89% Short Ratio1.64 Perf Half Y-6.37%
Book/sh10.73 P/B3.68 EPS next Y18.73% ROA-0.40% Target Price43.36 Perf Year5.55%
Cash/sh1.20 P/C33.06 EPS next 5Y6.55% ROE-0.80% 52W Range24.10 - 42.37 Perf YTD9.99%
Dividend- P/FCF50.64 EPS past 5Y14.60% ROI-0.30% 52W High-6.68% Beta0.88
Dividend %- Quick Ratio1.50 Sales past 5Y5.80% Gross Margin64.60% 52W Low64.07% ATR0.99
Employees38000 Current Ratio1.80 Sales Q/Q-6.70% Oper. Margin-0.80% RSI (14)59.25 Volatility2.57% 2.38%
OptionableYes Debt/Eq0.60 EPS Q/Q283.00% Profit Margin-1.20% Rel Volume1.15 Prev Close37.93
ShortableYes LT Debt/Eq0.60 EarningsFeb 03 BMO Payout- Avg Volume11.12M Price39.54
Recom1.70 SMA202.17% SMA506.61% SMA2006.30% Volume12,790,625 Change4.24%
Sep-17-20Initiated Truist Buy $47
Sep-11-20Initiated Wolfe Research Peer Perform $46
Apr-22-20Downgrade SVB Leerink Outperform → Mkt Perform $40
Apr-01-20Upgrade Goldman Neutral → Buy $46 → $38
Mar-05-20Initiated Citigroup Buy $48
Feb-13-20Initiated Goldman Neutral $46
Feb-06-20Resumed BTIG Research Buy $46
Dec-30-19Reiterated Cowen Outperform $47 → $52
Dec-19-19Downgrade Needham Strong Buy → Buy $53
Sep-05-19Resumed JP Morgan Overweight $50
Sep-03-19Resumed Barclays Overweight $48
May-13-19Upgrade Evercore ISI In-line → Outperform
Nov-28-18Initiated UBS Buy
Oct-16-18Initiated Barclays Overweight $43
Oct-02-18Reiterated Morgan Stanley Overweight $38 → $48
Sep-07-18Reiterated Needham Strong Buy $39 → $43
Sep-04-18Upgrade Jefferies Hold → Buy
Jul-06-18Reiterated Needham Strong Buy
Jun-27-18Initiated Bernstein Outperform $38
Apr-26-18Reiterated Needham Strong Buy $35 → $36
Mar-05-21 11:30AM  
Boston Scientific (BSX) Down 2.1% Since Last Earnings Report: Can It Rebound?
Zacks
Mar-04-21 09:59AM  
Boston Scientific (BSX) Buys Lumenis to Expand in Urology
Zacks
Mar-03-21 07:46AM  
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
Benzinga
07:12AM  
UPDATE 1-Boston Scientific to buy surgical business of Lumenis for $1.07 bln
Reuters
07:00AM  
Boston Scientific to spend $1.1 billion in cash to buy Lumentis LTD's surgical business
MarketWatch
06:58AM  
Baring agrees to sell Lumenis surgical business to Boston Scientific for $1.07 bln
Reuters
06:50AM  
Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity Asia
PR Newswire
Feb-26-21 01:16PM  
7 Stocks to Sell for March
InvestorPlace
Feb-23-21 04:20PM  
This Medical Stock Just Retook Its Buy Point On Its Unexpected Earnings Beat
Investor's Business Daily
09:40AM  
This Medical Stock Just Retook Its Buy Point On Unexpected Earnings Beat
Investor's Business Daily
Feb-12-21 09:30AM  
Boston Scientific Announces February and March 2021 Conference Schedule
PR Newswire
Feb-11-21 08:30AM  
Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027
PR Newswire
Feb-09-21 09:41AM  
Boston Scientific (BSX) Hurt by Product Recall, Conversion
Zacks
Feb-03-21 04:27PM  
Boston Scientific Recoups Earlier Losses On Potential Guidance Upside
Investor's Business Daily
01:30PM  
Boston Scientific Corp (BSX) Q4 2020 Earnings Call Transcript
Motley Fool
10:42AM  
Boston Scientific (BSX) Q4 Earnings Miss, Margins Decline
Zacks
07:55AM  
Boston Scientific (BSX) Q4 Earnings and Revenues Lag Estimates
Zacks
07:23AM  
Recap: Boston Scientific Q4 Earnings
Benzinga
06:48AM  
Boston Scientific stock falls after profit and sales miss, downbeat outlook
MarketWatch
06:30AM  
Boston Scientific Announces Results For Fourth Quarter And Full Year 2020
PR Newswire
12:05AM  
Has Boston Scientific (NYSE:BSX) Got What It Takes To Become A Multi-Bagger?
Simply Wall St.
Feb-02-21 01:36PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 2, 2021 - BSX
Newsfile
12:05PM  
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:00PM  
CLASS ACTION UPDATE for BSX, SWI and JFU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
11:00AM  
BSX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021
ACCESSWIRE
09:30AM  
Lawsuits Filed Against BSX, SWI and JFU - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
09:11AM  
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Boston Scientific Corporation and Encourages Investors with Losses of $100,000 to Contact the Firm
Business Wire
08:41AM  
BSX Final Deadline Today: Rosen, National Trial Counsel, Reminds Boston Scientific Corporation Investors of Important February 2 Deadline in Securities Class Action - BSX
Newsfile
06:30AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BSX, SWI and OTGLY
ACCESSWIRE
01:50AM  
BOSTON SCIENTIFIC 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Boston Scientific Corporation - BSX
PR Newswire
Feb-01-21 01:19PM  
BSX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 2, 2021 in the Class Action Filed on Behalf of Boston Scientific Corporation Limited Shareholders
Newsfile
11:49AM  
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
PR Newswire
11:16AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 2, 2021 - BSX
Newsfile
11:00AM  
BSX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021
GlobeNewswire
09:43AM  
BSX FILING DEADLINE TOMORROW: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Boston Scientific Corporation
PR Newswire
09:41AM  
BSX FINAL DEADLINE TOMORROW: ROSEN, TOP RANKED INVESTOR COUNSEL, Reminds Boston Scientific Corporation Investors of Important February 2 Deadline in Securities Class Action BSX
GlobeNewswire
07:30AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BSX, NAK and PEN
ACCESSWIRE
06:20AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BSX, GDRX and JFU
ACCESSWIRE
Jan-31-21 11:00PM  
FINAL DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
10:50PM  
BOSTON SCIENTIFIC 48 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Boston Scientific Corporation - BSX
Newsfile
10:20AM  
CLASS ACTION UPDATE for BSX, PEN and GDRX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
05:33AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadline - BSX
CNW Group
05:00AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadline - BSX
PR Newswire
Jan-30-21 11:21PM  
BSX FILING DEADLINE IN 4 DAYS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Boston Scientific Corporation
GlobeNewswire
02:15PM  
Final Deadline Notice: Rosen, Top Ranked National Investor Attorneys, Encourages Boston Scientific Corporation Investors with Large Losses to Secure Counsel Before Important Deadline - BSX
Newsfile
11:45AM  
FINAL DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Jan-29-21 10:50PM  
BOSTON SCIENTIFIC 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Boston Scientific Corporation - BSX
Business Wire
02:10PM  
SHAREHOLDER ALERT: BSX OTGLY AZN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
01:20PM  
FEBRUARY 2 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:00PM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BSX, DECN and JFU
ACCESSWIRE
11:00AM  
BSX Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Investors of Class Action and Lead Plaintiff Deadline: February 3, 2021
ACCESSWIRE
10:30AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 2, 2021 - BSX
Newsfile
09:00AM  
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Boston Scientific Corporation (BSX)
Business Wire
Jan-28-21 12:45PM  
Lawsuits Filed Against BSX, NAK and QIWI - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
12:00PM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Boston Scientific Corporation (BSX)
GlobeNewswire
11:45AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:00AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BSX, QS and AZN
ACCESSWIRE
10:00AM  
BSX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021
Newsfile
08:00AM  
Boston Scientific Corporation Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
GlobeNewswire
06:17AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 2, 2021 - BSX
Newsfile
Jan-27-21 11:04PM  
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BSX, SPLK INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
GlobeNewswire
07:40PM  
LAWSUITS FILED AGAINST BSX, KNDI and QS - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
07:17PM  
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors with Losses in Excess of $50,000 to Contact the Firm
PR Newswire
03:30PM  
CLASS ACTION UPDATE for BSX, PEN and CLSK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
02:40PM  
BREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors with Large Losses to Secure Counsel Before Important Deadline - BSX
ACCESSWIRE
01:00PM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BSX, TCDA and DECN
ACCESSWIRE
12:45PM  
FEBRUARY 3 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:45AM  
SHAREHOLDER ALERT: BSX TCDA DECN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
11:00AM  
BSX Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021
ACCESSWIRE
09:00AM  
Boston Scientific (BSX) LOTUS Edge Recall to Mar Q4 Earnings
Zacks
06:24AM  
BSX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 2, 2021 in the Class Action Filed on Behalf of Boston Scientific Corporation Limited Shareholders
Newsfile
Jan-26-21 10:40PM  
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BSX and SPLK
GlobeNewswire
02:21PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 2, 2021 - BSX
Newsfile
01:49PM  
15 Best Beaten Down Stocks to Buy Now
Insider Monkey
11:35AM  
FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:00AM  
DEADLINE ALERT for SPLK, BSX, QIWI and PEN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
11:00AM  
BSX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021
Business Wire
10:50AM  
CLASS ACTION UPDATE for BSX, BTBT and CLSK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
09:52AM  
BSX FILING DEADLINE IN 1 WEEK: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Boston Scientific Corporation
Newsfile
09:10AM  
Boston Scientific's (BSX) DBS System Gets FDA's Clearance
Zacks
06:20AM  
Lawsuits Filed Against BSX, QIWI and SWI - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
06:16AM  
Investing in These Stocks Could Make You a Millionaire Retiree
Motley Fool
Jan-25-21 10:50PM  
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BSX, SPLK INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
GlobeNewswire
09:38PM  
BSX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 2, 2021 in the Class Action Filed on Behalf of Boston Scientific Corporation Limited Shareholders
Newsfile
08:11PM  
Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who Purchased Boston Scientific Corporation Securities
PR Newswire
02:13PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 2, 2021 - BSX
Newsfile
12:45PM  
FEBRUARY 2 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:07PM  
ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Boston Scientific Corporation Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact Firm BSX
GlobeNewswire
11:30AM  
DEADLINE ALERT for FBIO, SPLK, and BSX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
11:30AM  
BSX FILING DEADLINE IN 8 DAYS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Boston Scientific Corporation
ACCESSWIRE
11:00AM  
BSX Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021
ACCESSWIRE
06:20AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BSX, NAK and QSR
ACCESSWIRE
12:40AM  
FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Jan-24-21 10:20AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BSX, GDRX and CLSK
ACCESSWIRE
07:30AM  
SHAREHOLDER ALERT; Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadline BSX
ACCESSWIRE
Jan-23-21 11:50AM  
ROSEN, A TOP RANKED LAW FIRM, Reminds Boston Scientific Corporation Investors of Important February 2 Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact Firm - BSX
Newsfile
Jan-22-21 10:50PM  
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BSX, SPLK INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
GlobeNewswire
01:45PM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BSX, PEN and TRIT
ACCESSWIRE
12:15PM  
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:45AM  
CLASS ACTION UPDATE for BSX, TCDA and BTBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fitzgerald Joseph MichaelEVP & Pres, Interven CardioMar 03Option Exercise0.003,6030252,559Mar 04 04:07 PM
Brennan Daniel J.EVP and CFOMar 03Sale38.6912,127469,177263,243Mar 04 04:07 PM
Pierce David AEVP Pres MedSurgMar 02Sale38.901,36052,9049,660Mar 04 04:07 PM
Brennan Daniel J.EVP and CFOMar 02Sale38.849,475368,034275,370Mar 04 04:07 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 28Option Exercise0.001,6290245,625Mar 02 04:16 PM
Meredith Ian TEVP Global Chief Med OfficerFeb 28Option Exercise0.001,018032,852Mar 02 04:15 PM
Monson JonathanVP, Global Controller and CAOFeb 28Option Exercise0.00815037,297Mar 02 04:14 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 28Option Exercise0.002,0370140,087Mar 02 04:14 PM
Mahoney Michael FChairman, President & CEOFeb 28Option Exercise0.0018,33002,124,917Mar 02 04:14 PM
Mackey Edward FEVP, OperationsFeb 28Option Exercise0.002,444092,979Mar 02 04:14 PM
Butcher Arthur CEVP&Pres, Asia PacificFeb 28Option Exercise0.001,528035,420Mar 02 04:14 PM
Eddy Jodi EuerleSVP, Chief Info & Digital Off.Feb 28Option Exercise0.001,426021,216Mar 02 04:14 PM
Carruthers WendySVP, Human ResourcesFeb 28Option Exercise0.001,6290194,446Mar 02 04:14 PM
Brennan Daniel J.EVP and CFOFeb 28Option Exercise0.004,4810286,833Mar 02 04:14 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 28Option Exercise0.001,8330108,863Mar 02 04:16 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 28Option Exercise0.001,222050,866Mar 02 04:16 PM
Olson ScottSVP & Pres, Rhythm ManagementFeb 28Option Exercise0.001,426014,248Mar 02 04:16 PM
Scanlon MeghanSVP,Pres,Urology Pelvic HealthFeb 28Option Exercise0.001,018016,673Mar 02 04:16 PM
Pierce David AEVP Pres MedSurgFeb 28Option Exercise0.002,444012,104Mar 02 04:16 PM
Brennan Daniel J.EVP and CFOFeb 23Option Exercise7.1624,846177,897307,198Feb 24 04:07 PM
Pierce David AEVP Pres MedSurgFeb 23Sale39.202,836111,1719,660Feb 24 04:07 PM
Brennan Daniel J.EVP and CFOFeb 23Sale39.2324,846974,704282,352Feb 24 04:07 PM
Pierce David AEVP Pres MedSurgFeb 22Option Exercise0.002,607013,653Feb 23 05:15 PM
Scanlon MeghanSVP,Pres,Urology Pelvic HealthFeb 22Option Exercise0.001,159015,993Feb 23 05:15 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 22Option Exercise0.002,3180139,108Feb 23 05:13 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 22Option Exercise0.001,8830244,648Feb 23 05:13 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 22Option Exercise0.002,0280108,129Feb 23 05:15 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 22Option Exercise0.001,594050,132Feb 23 05:15 PM
Brennan Daniel J.EVP and CFOFeb 22Option Exercise0.005,7940284,922Feb 23 05:11 PM
Fitzgerald Joseph MichaelEVP & Pres, Interven CardioFeb 22Option Exercise0.004,0560250,958Feb 23 05:12 PM
Eddy Jodi EuerleSVP, Chief Info & Digital Off.Feb 22Option Exercise0.001,738020,301Feb 23 05:12 PM
Mahoney Michael FChairman, President & CEOFeb 22Option Exercise0.0023,17502,116,866Feb 23 05:12 PM
Mackey Edward FEVP, OperationsFeb 22Option Exercise0.002,897091,820Feb 23 05:12 PM
Carruthers WendySVP, Human ResourcesFeb 22Option Exercise0.002,3180193,498Feb 23 05:12 PM
Butcher Arthur CEVP&Pres, Asia PacificFeb 22Option Exercise0.001,014036,988Feb 23 05:11 PM
Monson JonathanVP, Global Controller and CAOFeb 22Option Exercise0.001,159036,835Feb 23 05:13 PM
Monson JonathanVP, Global Controller and CAOFeb 21Option Exercise0.00623035,895Feb 23 05:13 PM
Butcher Arthur CEVP&Pres, Asia PacificFeb 21Option Exercise0.001,713036,635Feb 23 05:11 PM
Carruthers WendySVP, Human ResourcesFeb 21Option Exercise0.001,5580191,638Feb 23 05:12 PM
Mackey Edward FEVP, OperationsFeb 21Option Exercise0.002,726090,132Feb 23 05:12 PM
Mahoney Michael FChairman, President & CEOFeb 21Option Exercise0.0016,82402,101,153Feb 23 05:12 PM
Eddy Jodi EuerleSVP, Chief Info & Digital Off.Feb 21Option Exercise0.00934018,838Feb 23 05:12 PM
Fitzgerald Joseph MichaelEVP & Pres, Interven CardioFeb 21Option Exercise0.003,8940248,824Feb 23 05:12 PM
Brennan Daniel J.EVP and CFOFeb 21Option Exercise0.003,6610280,752Feb 23 05:11 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 21Option Exercise0.001,090048,872Feb 23 05:15 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 21Option Exercise0.001,7130107,029Feb 23 05:15 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 21Option Exercise0.001,7130243,358Feb 23 05:13 PM
Meredith Ian TEVP Global Chief Med OfficerFeb 21Option Exercise0.001,012032,132Feb 23 05:13 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 21Option Exercise0.002,8040137,759Feb 23 05:13 PM
Olson ScottSVP & Pres, Rhythm ManagementFeb 21Option Exercise0.001,090013,351Feb 23 05:14 PM
Scanlon MeghanSVP,Pres,Urology Pelvic HealthFeb 21Option Exercise0.00779015,057Feb 23 05:15 PM
Ralls-Morrison DesireeSVP, GC and Corp SecretaryFeb 21Option Exercise0.001,324030,298Feb 23 05:15 PM
Pierce David AEVP Pres MedSurgFeb 21Option Exercise0.002,492012,152Feb 23 05:15 PM
Pierce David AEVP Pres MedSurgFeb 19Sale38.001,48456,3929,660Feb 23 05:15 PM
Ralls-Morrison DesireeSVP, GC and Corp SecretaryFeb 18Option Exercise0.001,704029,475Feb 19 04:25 PM
Scanlon MeghanSVP,Pres,Urology Pelvic HealthFeb 18Option Exercise0.001,111014,650Feb 19 04:25 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 18Option Exercise0.002,8160135,817Feb 19 04:20 PM
Monson JonathanVP, Global Controller and CAOFeb 18Option Exercise0.00637035,496Feb 19 04:20 PM
Meredith Ian TEVP Global Chief Med OfficerFeb 18Option Exercise0.001,037031,425Feb 19 04:20 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 18Option Exercise0.001,7780242,260Feb 19 04:21 PM
Mahoney Michael FChairman, President & CEOFeb 18Option Exercise0.0016,30602,091,561Feb 19 04:20 PM
Fitzgerald Joseph MichaelEVP & Pres, Interven CardioFeb 18Option Exercise0.003,7060246,759Feb 19 04:18 PM
Mackey Edward FEVP, OperationsFeb 18Option Exercise0.002,223088,392Feb 19 04:18 PM
Butcher Arthur CEVP&Pres, Asia PacificFeb 18Option Exercise0.002,371035,928Feb 19 04:15 PM
Carruthers WendySVP, Human ResourcesFeb 18Option Exercise0.001,8530190,624Feb 19 04:15 PM
Eddy Jodi EuerleSVP, Chief Info & Digital Off.Feb 18Option Exercise0.001,111018,231Feb 19 04:16 PM
Brennan Daniel J.EVP and CFOFeb 18Option Exercise0.003,7060278,735Feb 19 04:14 PM
Olson ScottSVP & Pres, Rhythm ManagementFeb 18Option Exercise0.001,037012,803Feb 19 04:24 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 18Option Exercise0.001,185048,145Feb 19 04:24 PM
Pierce David AEVP Pres MedSurgFeb 18Option Exercise0.002,668012,328Feb 19 04:24 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 18Option Exercise0.002,0010106,400Feb 19 04:24 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 17Option Exercise7.4732,353241,677104,399Feb 19 04:24 PM
Pierce David AEVP Pres MedSurgFeb 16Sale38.281,54058,9519,660Feb 17 04:16 PM
Pierce David AEVP Pres MedSurgFeb 15Option Exercise0.002,768012,428Feb 17 04:16 PM
Monson JonathanVP, Global Controller and CAOFeb 15Option Exercise0.00738035,118Feb 17 04:15 PM
Carruthers WendySVP, Human ResourcesFeb 15Option Exercise0.001,6610189,259Feb 17 04:14 PM
Fitzgerald Joseph MichaelEVP & Pres, Interven CardioFeb 15Option Exercise0.004,6140245,331Feb 17 04:14 PM
Mackey Edward FEVP, OperationsFeb 15Option Exercise0.002,768087,397Feb 17 04:14 PM
Eddy Jodi EuerleSVP, Chief Info & Digital Off.Feb 15Option Exercise0.00923017,391Feb 17 04:14 PM
Mahoney Michael FChairman, President & CEOFeb 15Option Exercise0.0018,45702,083,441Feb 17 04:14 PM
Meredith Ian TEVP Global Chief Med OfficerFeb 15Option Exercise0.001,107030,713Feb 17 04:14 PM
Butcher Arthur CEVP&Pres, Asia PacificFeb 15Option Exercise0.001,846034,360Feb 17 04:12 PM
Brennan Daniel J.EVP and CFOFeb 15Option Exercise0.004,1530276,871Feb 17 04:11 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 15Option Exercise0.001,6610241,057Feb 17 04:16 PM
Olson ScottSVP & Pres, Rhythm ManagementFeb 15Option Exercise0.001,292012,473Feb 17 04:16 PM
Ralls-Morrison DesireeSVP, GC and Corp SecretaryFeb 15Option Exercise0.001,107028,096Feb 17 04:16 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 15Option Exercise0.002,0300133,623Feb 17 04:15 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 15Option Exercise0.001,200047,328Feb 17 04:17 PM
Scanlon MeghanSVP,Pres,Urology Pelvic HealthFeb 15Option Exercise0.001,107013,927Feb 17 04:16 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 15Option Exercise0.001,846073,046Feb 17 04:18 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventFeb 12Sale38.755,494212,892131,593Feb 17 04:15 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrFeb 12Sale38.6528,8831,116,35471,200Feb 17 04:18 PM
Butcher Arthur CEVP&Pres, Asia PacificFeb 08Option Exercise13.089,000117,72045,025Feb 10 04:08 PM
Butcher Arthur CEVP&Pres, Asia PacificFeb 08Sale39.3916,902665,81228,123Feb 10 04:08 PM
Pierce David AEVP Pres MedSurgFeb 04Sale38.0011,317430,0462,057Feb 08 05:28 PM
Meredith Ian TEVP Global Chief Med OfficerFeb 01Option Exercise0.003,130027,475Feb 03 04:14 PM
Brennan Daniel J.EVP and CFOJan 05Sale35.3217,083603,407263,243Jan 06 04:18 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventJan 05Sale35.318,108286,333131,636Jan 06 04:18 PM
Olson ScottSVP & Pres, Rhythm ManagementJan 04Sale36.0870025,25611,181Jan 05 04:20 PM
Thepaut Eric Francis YvesEVP & Pres, Eur, Mid-East, AfrJan 01Option Exercise0.0010,8790102,675Jan 05 04:20 PM
open in yahoo | open in reuters | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.